Clinical trial NCT02898363: Awareness on Cancer in Persons With Intellectual Disabilities
Official title: Awareness on Cancer in Persons With Intellectual Disabilities
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Cancer
Keywords: Care of disabled population
Mental retardation
Cancer screening
Cancer prevention
Lead sponsor: Centre Hospitalier Universitaire de Nīmes
Sponsor class: OTHER
First posted: 2016-09-13
Enrollment: 80
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: ECOLOGIC_OR_COMMUNITY
Time perspective: PROSPECTIVE
Sampling method: PROBABILITY_SAMPLE
Study population: The study population is all adults with intellectual disabilities residing in the Hérault department of France who have been diagnosed with cancer

Brief summary: Context People with intellectual disability (PWIDs), nearly 1,300,000 adults and children in France, develop as many cancers as persons in the general population. However, their tumors are different by their particular organ distribution, the age of onset, the biological background (2,000 genetic conditions are associated with an intellectual disability) and above all the unusual clinical presentation. These cancers are not well known from physicians, carers and families, and often discovered late. A recent review of the literature shows many inequalities in the prevention, monitoring, screening, diagnosis and treatment of cancer in these patients. Currently, no population study on clinical features and stage at diagnosis of cancer in PWIDs is available. No interventional research study has been conducted on this subject.

Hypothesis Investigators hypothesize that inequalities in cancer care of PWIDs do not result from a direct link between intellectual disability and cancer, but are related to diagnosis difficulties of these tumors which are not well known, and to difficulties of communication with these patients who do not express easily their symptoms, particularly pain.

Detailed description: The study will first evaluate characteristics of all cancers diagnosed in PWIDs in the department of Hérault (20,000 PWIDs) during the four-year period preceding the intervention. Investigators will cross the data of social network of PWIDs (CREAI Languedoc Roussillon) which covers nearly 90% of PWIDs living in this area, and the Hérault Cancer Registry. Second, during a two-year information program, physicians, mainly general practitioners, carers in and outside institutions, associations and families will be informed on cancer frequency, on cancer particularities and on cancer detection in PWIDs by the mean of documents, mails and e-mails, meetings and a website providing all available useful information on cancer in PWIDs. Third, characteristics of tumors observed during the three years after the beginning of the intervention will be statistically compared to the corresponding tumors before the intervention. This will be done especially for colon cancer and breast cancer using the TNM stage and the used therapeutic means. On the basis of the first part of the study, if a significant difference on stage at diagnosis and treatment is observed compared to the general population, other tumors will also be included in the comparison, if relevant.

Eligibility criteria: Inclusion Criteria:

* Persons with intellectual disabilities according to the World Health Organization definition
* Residing in the Hérault department of France
* Diagnosis of a malign invasive or in-situ tumor

Exclusion Criteria:

* Refusal of study participation following provision of information (refusal by the patient, or his/her guardian, or principal caregiver)

Primary outcomes:
measure: Cancer incidence among persons with intellectual disabilities
timeFrame: Change from baseline (i.e. years -4 through -1) to years 1 through 3
Secondary outcomes:
Other outcomes:
Locations:
city: Montpellier Cedex 5
country: France
facility: IURC - Laboratoire de Biostatistique d'Epidémiologie et de Recherche Clinique
Study officials:
affiliation: IURC - Laboratoire de Biostatistique d'Epidémiologie et de Recherche Clinique
name: Daniel Satgé, MD, PhD
role: STUDY_DIRECTOR
References: